Resource Links

Status	Official Title	Lead Investigator	Last Updated
Finalised	Post-authorization Safety Study Evaluation of Cardiovascular Events in Users of Mirabegron and Other Treatments for Overactive Bladder	Dr John Seeger	28/04/2020
Finalised	Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder : Core Common Protocol	Dr John Seeger	18/11/2019
Finalised	Incidence of Pancreatic Malignancy and Thyroid Neoplasm in Type 2 Diabetes Mellitus Patients who Initiate Exenatide Compared to Other Antihyperglycemic Drugs - Phase 2 (Extended Accrual and Follow-Up)	Dr Caihua Liang	28/06/2018
Finalised	Hepatic Outcomes Among Adults Taking Duloxetine in	Dr Hu Li	03/08/2017
Ongoing	Risk Prediction, Prognosis and Management of Cardiac Events among Patients with Multiple Myeloma (20160220)	Dr Global Development Leader Amgen Inc.	02/02/2017
Ongoing	One Year Post-discharge Clinical and Economic Outcomes among Patients with ACS Managed with PCI and Treated with Prasugrel versus Clopidogrel	Dr Cliff Molife	12/05/2016
Planned	Multisource Surveillance Study of Pregnancy and Infant Outcomes in Ocrelizumab-Exposed Women With Multiple Sclerosis	Dr Margulis Andrea	05/03/2020